SMC accepts four medicines for NHS use
Biogen’s Famprya, Sanofi’s Suliqua, Janssen’s Stelara and Shionogi Rizmoic will be funded on the NHS in Scotland
Read More
Tag: suliqua
Suliqua launches in UK
The approval is based on two phase III studies, LixiLan-O and LixiLan-L.
Read More
EU approval for Sanofi’s diabetes combo
Sanofi-Aventis’ Suliqua has been approved in the European Union expanding treatment options for people with type II diabetes.
Read More
Nine therapies put forward for EU approval
Nine therapies spanning a range of diseases have been recommended for approval by the European Medicines Agency’s Committee for Medicinal Products for Human Use, including three biosimilars and two diabetes drugs.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
